Much of what people assume to be true about big business is completely wrong. Rob Atkinson and Michael Lind cover five of the most egregious examples in this Innovation Files post.
September 24, 2018
September 17, 2018
Given that the modern economy tends to be described as globalized and that recent policy debates have been centered on whether globalization has been good at all, it is easy to overlook how much more integrated the world could become and the good that course could bring. Through artificial intelligence, one of the largest barriers to globalization that still exists, language, is beginning to crumble.
September 12, 2018
The lesson for EU policymakers is clear: do not get seduced by the idea that stringent privacy regulation is a shortcut for digital growth. Enacting even stricter data protection rules, such as the pending ePrivacy Regulation, will come with costs that will hurt not only the EU digital ecosystem but also EU digital consumers.
September 10, 2018
Fact of the Week: Federal R&D Contracts That Operate as Cooperative Agreements are More Likely to Result in Patents
Federal funding of private R&D comes in two forms: grants, in which the government has very little interaction with the research decisions made, and cooperative agreements, in which the government has significant control over research decisions and much more detailed project monitoring. Whether this higher level of government involvement hinders researchers by increasing bureaucracy or ensures that funding is not misallocated is hotly contested, but a paper released in June gives reason to believe that cooperative agreements are used well.
September 10, 2018
A truly successful 5G deployment will depend on the cooperation between operators and cities where they deploy. The FCC’s latest actions hopefully will curtail outlier authorities charging outsized fees or otherwise stonewalling deployment. But the hard work still lies ahead.
September 4, 2018
Debates over high-priced prescription drugs tend to focus on whether the government should attempt to constrict the pharmaceutical industry, whether by reducing patent protections or by mandating lower prices. What these conversations miss, though, is that drug prices could also fall through the expansion of the pharmaceutical industry, rather than its restriction.
August 27, 2018
A body of academic research has shown that high-skill immigration has a significant positive effect on the number of patents companies file. But according to a study published last month, past research may have underestimated the impact H-1B workers have on innovation more broadly.
August 24, 2018
Verizon finds itself in the hot seat after it apparently slowed data communications of fire fighters in California who exceeded a pre-set threshold on their “unlimited” mobile plan. The incident has little to nothing to do with net neutrality and does not show why we need the old Title II-based rules, but it does provide a useful example of how net neutrality advocates will take advantage of bad optics to push for expansive regulation.
August 24, 2018
A contagion of poor public policy is sweeping across Latin America in the form of the spreading use of compulsory licenses on novel pharmaceutical drugs, and it threatens to undermine the very ecosystem supporting the development of medicines designed to treat deadly diseases in the first place.
August 23, 2018
The struggle to reunite separated families is the result of a myriad of issues, but the federal government’s poor data management made the situation worse. Federal agencies need to continue to update their practices and systems to better collect, share, and make available accurate information.